Advertisement
Advertisement
ORMP
Oramed Pharmaceuticals Inc.
3.69
USDSponsored
-0.20
-5.14%
Nov 19, 15:59 UTC -5
Closed
After-Market
3.85
+0.16
+4.34%
Oramed Pharmaceuticals Inc. (ORMP) Earnings
ORMP Earnings Reports
Positive Surprise Ratio
ORMP beat 13 of 18 last estimates.
72%
Next Report
Date of Next Report
Mar 24, 2027
Estimate for Q4 26 (Revenue/ EPS)
--
/$0.37
Implied change from Q3 26 (Revenue/ EPS)
--
/-13.95%
Implied change from Q4 25 (Revenue/ EPS)
--
/+54.17%
Oramed Pharmaceuticals Inc. earnings per share and revenue
On Nov 12, 2026, ORMP reported earnings of 0.43 USD per share (EPS) for Q3 26, missing the estimate of 0.43 USD, resulting in a -1.96% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -7.94% price change (close before vs. close after earnings).
Looking ahead to Q4 26, -- analysts forecast an EPS of 0.37 USD, with revenue projected to reach -- USD, implying an decrease of -13.95% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Omeros Corporation
Report Date
Nov 16, 2026 For Q3 26
Estimate
$0.03
Actual
$0.06
Surprise
+96.08%

Sanara MedTech Inc. Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
$0.06
Actual
-$0.16
Surprise
-361.44%

MacroGenics, Inc.
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.06
Actual
-$0.32
Surprise
-367.15%

Glass House Brands Inc.
Report Date
Nov 16, 2026 For Q3 26
Estimate
-$0.04
Actual
-$0.14
Surprise
-191.06%

Immucell Corp
Report Date
Nov 12, 2026 For Q3 26
Estimate
-Actual
$0.10
Surprise
-

FitLife Brands, Inc. Common Stock
Report Date
Nov 16, 2026 For Q3 26
Estimate
$0.24
Actual
$0.16
Surprise
-34.64%

Rockwell Medical, Inc. (DE) Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.13
Actual
-$0.37
Surprise
-179.03%

Modular Medical, Inc. Common Stock
Report Date
Nov 16, 2026 For Q2 26
Estimate
-$0.10
Actual
-$0.90
Surprise
-782.35%

Cytosorbents Corp.
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.91
Actual
-$0.57
Surprise
+36.82%

Agape ATP Corporation Common Stock
Report Date
Nov 16, 2026 For Q3 26
Estimate
-Actual
-$0.08
Surprise
-
FAQ
What were Oramed Pharmaceuticals Inc.'s earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Oramed Pharmaceuticals Inc. reported EPS of $0.43, missing estimates by -1.96%, and revenue of $0.00, 0% as expectations.
How did the market react to Oramed Pharmaceuticals Inc.'s Q3 2026 earnings?
The stock price moved down -7.94%, changed from $4.03 before the earnings release to $3.71 the day after.
When is Oramed Pharmaceuticals Inc. expected to report next?
The next earning report is scheduled for Mar 24, 2027.
What are the forecasts for Oramed Pharmaceuticals Inc.'s next earnings report?
Based on --
analysts, Oramed Pharmaceuticals Inc. is expected to report EPS of $0.37 and revenue of -- for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.